Oruka Therapeutics (ORKA) Net Cash Flow Growth (5y) (2015 - 2026)
Oruka Therapeutics (ORKA) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
| 10 |
Oruka Therapeutics |
3.86 Bn |
3.47 Bn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-32.06% |
| Dec 31, 2025 |
-85.40% |
| Sep 30, 2025 |
-8.38% |
| Jun 30, 2025 |
-77.23% |
| Mar 31, 2025 |
71.93% |
| Dec 31, 2024 |
-206.95% |
| Sep 30, 2024 |
315.78% |
| Jun 30, 2024 |
-53.20% |
| Mar 31, 2024 |
81.77% |
| Dec 31, 2023 |
6.12% |
| Sep 30, 2023 |
-1.11% |
| Jun 30, 2023 |
22.37% |
| Mar 31, 2023 |
-19.82% |
| Dec 31, 2022 |
-36.09% |
| Sep 30, 2022 |
-21.10% |
| Jun 30, 2022 |
-23.68% |
| Mar 31, 2022 |
-28.42% |
| Dec 31, 2021 |
-48.16% |
| Sep 30, 2021 |
4.92% |
| Jun 30, 2021 |
24.61% |
